A detailed history of Cwm, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 481 shares of IDYA stock, worth $13,357. This represents 0.0% of its overall portfolio holdings.

Number of Shares
481
Previous 412 16.75%
Holding current value
$13,357
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$30.37 - $43.05 $2,095 - $2,970
69 Added 16.75%
481 $15,000
Q2 2024

Jul 09, 2024

BUY
$34.37 - $43.46 $412 - $521
12 Added 3.0%
412 $14,000
Q1 2024

Apr 05, 2024

BUY
$34.2 - $47.13 $68 - $94
2 Added 0.5%
400 $18,000
Q4 2023

Feb 01, 2024

SELL
$24.59 - $35.83 $2,262 - $3,296
-92 Reduced 18.78%
398 $14,000
Q3 2023

Oct 11, 2023

BUY
$21.07 - $29.77 $1,938 - $2,738
92 Added 23.12%
490 $13,000
Q3 2022

Oct 27, 2022

BUY
$9.24 - $15.79 $3,677 - $6,284
398 New
398 $6,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.33B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.